Insights
Featured Carousel
- Insights – September 2025
- The Informed Board – Summer 2025
- Insights: The Delaware Edition
- Latest Updates on the Trump Administration
- Trump Administration Regulatory Litigation Tracker
Topics Panel Section
Bank of England Revises Its Proposed Regime for Regulating ‘Systemic’ Stablecoins
Bank of England proposals for regulating sterling-denominated stablecoins have shifted since 2023, but remain significantly more onerous than the FCA’s proposals for non-systemic stablecoins in many respects.
Bank of England Revises Its Proposed Regime for Regulating ‘Systemic’ Stablecoins
EU Adopts 19th Russia Sanctions Package Alongside New Sanctions Being Imposed by US and UK
The EU’s 19th Russia sanctions package against Russia expands restrictions and puts into law ownership/control conditions.
EU Adopts 19th Russia Sanctions Package Alongside New Sanctions Being Imposed by US and UK
Bank of England proposals for regulating sterling-denominated stablecoins have shifted since 2023, but remain significantly more onerous than the FCA’s proposals for non-systemic stablecoins in many respects.
Bank of England Revises Its Proposed Regime for Regulating ‘Systemic’ Stablecoins
The EU’s 19th Russia sanctions package against Russia expands restrictions and puts into law ownership/control conditions.
EU Adopts 19th Russia Sanctions Package Alongside New Sanctions Being Imposed by US and UK
On November 10, 2025, BIS suspended the Affiliates Rule, which extended export restrictions to certain foreign entities owned by listed parties, for one year.
BIS Suspends Affiliates Rule for One Year as Part of the US-China Trade Deal
The FDA has updated its policy to reduce requirements for demonstrating biosimilarity. The changes should allow biosimilar companies to submit products to the agency sooner, potentially accelerating market entry and increasing biosimilar adoption.
FDA Policy Changes Could Bring Some Biosimilars to Market Faster
BIS Suspends Affiliates Rule for One Year as Part of the US-China Trade Deal
On November 10, 2025, BIS suspended the Affiliates Rule, which extended export restrictions to certain foreign entities owned by listed parties, for one year.
BIS Suspends Affiliates Rule for One Year as Part of the US-China Trade Deal
FDA Policy Changes Could Bring Some Biosimilars to Market Faster
The FDA has updated its policy to reduce requirements for demonstrating biosimilarity. The changes should allow biosimilar companies to submit products to the agency sooner, potentially accelerating market entry and increasing biosimilar adoption.
FDA Policy Changes Could Bring Some Biosimilars to Market Faster
